Active substance
Results for the substance alpha glucosidase
1 result
About this active substance
Alglucosidase alfa is a recombinant enzyme used in the treatment of Pompe disease, a rare genetic disorder caused by a deficiency of acid alpha-glucosidase (GAA). This condition leads to the accumulation of glycogen in cells, particularly in muscles, resulting in progressive muscle weakness and impairment of respiratory and cardiac function. Alglucosidase alfa is used as enzyme replacement therapy to reduce glycogen buildup and improve muscle function.
The mechanism of action of alglucosidase alfa involves providing a functional form of acid alpha-glucosidase, which is taken up by cells via mannose-6-phosphate receptors. Once inside lysosomes, the enzyme breaks down accumulated glycogen into glucose, thereby reducing cellular toxicity and improving muscle function.
Alglucosidase alfa is administered intravenously, typically once every two weeks, under the supervision of a specialist. The dosage is adjusted based on the patient’s body weight. Treatment is long-term and requires regular monitoring to assess efficacy and detect potential side effects.
While effective, alglucosidase alfa may cause side effects. The most common include infusion-related reactions such as fever, chills, rash, nausea, or difficulty breathing. In rare cases, severe allergic reactions (anaphylaxis) or the development of antibodies against the enzyme may occur, which can reduce the treatment’s effectiveness. Close monitoring of patients during administration is essential.
The mechanism of action of alglucosidase alfa involves providing a functional form of acid alpha-glucosidase, which is taken up by cells via mannose-6-phosphate receptors. Once inside lysosomes, the enzyme breaks down accumulated glycogen into glucose, thereby reducing cellular toxicity and improving muscle function.
Alglucosidase alfa is administered intravenously, typically once every two weeks, under the supervision of a specialist. The dosage is adjusted based on the patient’s body weight. Treatment is long-term and requires regular monitoring to assess efficacy and detect potential side effects.
While effective, alglucosidase alfa may cause side effects. The most common include infusion-related reactions such as fever, chills, rash, nausea, or difficulty breathing. In rare cases, severe allergic reactions (anaphylaxis) or the development of antibodies against the enzyme may occur, which can reduce the treatment’s effectiveness. Close monitoring of patients during administration is essential.